efficacy of adjunctive moxibustion in the treatment of Tuberculosis
- Conditions
- Tuberculosis
- Registration Number
- PACTR201504001033387
- Lead Sponsor
- Moxafrica
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- 180
Diagnosis of TB was by sputum smear
-If Patient has been on TB treatment; it is for not more than 2 weeks
-Patient should consent to join the study if he/she is to join it.
-Patient should have an attendant who may help him/her with the treatment.
-Patient is under the age of 18 years
-Patient who were judged to be unable to understand the instructions (of what they are to do while in the study e.g. how to use moxa)
-Patients intending to leave/change treatment center before their TB treatment duration ends
-Patients who are unable to come on all follow up visits
-History of Allergy to moxa/moxibustion
-Diabetic patients were excluded
-pregnant women
-Coexistance of a Type of TB, or any other illnesses that require the participants to take steroids in addition to TB medicine
-If TB was not diagnosed using sputum smears.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method